lignocaine+dexamethasone — Competitive Intelligence Brief

lignocaine+dexamethasone (lignocaine+dexamethasone) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic + corticosteroid combination. Area: Pain management, Anesthesia, Inflammation.

marketed Local anesthetic + corticosteroid combination Voltage-gated sodium channels (lignocaine); glucocorticoid receptor (dexamethasone) Pain management, Anesthesia, Inflammation Small molecule

Target snapshot

lignocaine+dexamethasone (lignocaine+dexamethasone) — Aligarh Muslim University. Lignocaine provides local anesthesia by blocking sodium channels in nerve fibers, while dexamethasone reduces inflammation and swelling at the injection site.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
lignocaine+dexamethasone TARGET	lignocaine+dexamethasone	Aligarh Muslim University	marketed	Local anesthetic + corticosteroid combination	Voltage-gated sodium channels (lignocaine); glucocorticoid receptor (dexamethasone)
Xylocaine and Dexamethasone	Xylocaine and Dexamethasone	University of Jordan	marketed	Local anesthetic + corticosteroid combination	Voltage-gated sodium channels (lidocaine); glucocorticoid receptor (dexamethasone)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic + corticosteroid combination class)

1. Aligarh Muslim University · 1 drug in this class
2. University of Jordan · 1 drug in this class